SCHEMBL27584343

SCHEMBL27584343

CC(C)(C)NC(=O)OC(CO)Cc1cccc(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 2/20 0.46
▸ CTSK P43235 2/20 0.46
▸ CTSS P25774 1/20 0.46
▸ SCN9A Q15858 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ RIPK1 Q13546 1/20 0.40
▸ PTGES O14684 1/20 0.38
▸ MAOB P27338 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ CTSL P07711 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28652918 0.86 SCN9A (0.39) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL28963352 0.86 CTSK (0.49) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL27794800 0.85 CTSK (0.49) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL14716956 0.85 CTSK (0.49) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL15311168 0.85 CTSK (0.49) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL28764261 0.78 ALDH1A1 (0.40) CTSBCTSKCTSSNPC1ALDH1A1
SCHEMBL28069939 0.78 ALDH1A1 (0.40) CTSBCTSKCTSSNPC1ALDH1A1
SCHEMBL27696093 0.78 SCN9A (0.45) CTSBCTSKCTSSSCN9ANPC1
SCHEMBL29096483 0.77 TRPA1 (0.43) CTSBCTSKCTSSSCN9ALMNA
SCHEMBL27503389 0.77 RAB9A (0.47) CTSBCTSKSCN9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1514833-A Novel tyrosine kinase inhibitors ����˹�ж�-����˹˹������˾ 2004-07-21 — — CN disclosed
Send feedback